| A randomized,double-blind,multicenter,Phase2,three-arm,placebo-control study of apatinib as third line treatment in patients with metastatic gastric carcinoma | |
| Jin Li; Nong Xu; Ying Cheng; Zhehai Wang; Leizhen Zheng; Min Tao; xiaodong Zhu; Dongmei Ji; Xin Liu; Shukui Qin | |
| 2012 | |
| 关键词 | gastric carcinoma treatment |
| 会议录 | 第十五届全国临床肿瘤学大会暨2012年CSCO学术年会
 |
| 语种 | 英语 |
| URL标识 | 查看原文 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4914302 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Jin Li,Nong Xu,Ying Cheng,et al. A randomized,double-blind,multicenter,Phase2,three-arm,placebo-control study of apatinib as third line treatment in patients with metastatic gastric carcinoma[C]. 见:. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论